Gilead Sciences, A Technical Look At A Biotechnology Stock

Gilead Sciences (GILD) has come on my radar now from two sources that find the stock fundamentally sound and management great.  After looking at this myself a little deeper I am ready for some technical analysis on it.  I'm usually careful with pharmaceuticals and biotechnology stocks simply due to the FDA approval/non-approval risk but if enough items line up even this sector should lend itself well for an educated try with probabilities in our favor.  

To the charts we go;

The weekly chart shows resistance at the downward-sloping trend line (blue dotted line) that currrently comes in around $42.50.  Not far above is the 200 week moving average at $44.  So, from a weekly perspective, should GILD be able to overcome those two points of resistance it should have fairly smooth sailing to around $49.

The daily chart looks even clearer.  Note the blue zone, which is a still unfilled gap from all the way back from April 2010. The gap fill would complete at $44.75, which…maybe coincidentally or not, is a -23.6% Fibonacci extension if you measure the move from the December 2010 lows to the highs in April 2011.  All in all, this is a good trade setup for a long-side try.

Stops depend on ones risk profile, but we are looking at $40 and target 1 at $43, target 2 $45ish, and target 3 as high as $49.

Happy Trading

Serge

Watch More:

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Serge’s Daily Trading Tips

Subscribe now and get clear, actionable, and relevant trade ideas!

By giving your contact info you agree to receive future emails from The Steady Trader including educational and promotional content. By providing your mobile phone number and clicking on the above “Subscribe” button, you agree to receive automated promotional messages from us via SMS. By opting into our SMS Program, you agree to our Terms and Conditions and Privacy Policy.